FORWARD FEATURES CALENDAR

Managers

Nigel Kneafsey, Options

Options secures significant growth investment from Bregal Sagemount

Options, a provider of cloud-enabled managed services to the global capital markets, has secured a significant investment from Bregal Sagemount, a New York-based private equity firm focused on growth-oriented investments. The transaction, which sees Bregal Sagemount invest nearly USD100 million in Options, will enable the firm’s executive team to pursue

PE deal volumes and valuations beginning to diverge, says Murray Devine report

Private equity deal volumes and valuations are beginning to diverge with the pace of PE investment activity slowing year over year while valuations have climbed to a 10-year high, according to Murray Devine’s inaugural H1 Private Equity Valuations Report. The report, which analyses data provide by PitchBook to examine trends

Private debt investors pursuing mezzanine funds, says Preqin

Preqin’s most recent survey finds that institutional investors view mezzanine funds as one of the most promising areas of the private debt market, leading to increased fundraising for the fund type in recent quarters. Almost half see mezzanine funds as offering the best risk/return profile, and four out of ten

Calculus Capital invests GBP2.5m in Axol Bioscience

Private equity firm Calculus Capital, a leading EIS and VCT investor, has completed its third deal in two weeks, investing GBP2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells produced from reprogrammed human blood and tissue cells. Axol supplies high quality human cells – especially live human neurons

HIG Capital acquires NCI, Inc

An affiliate of HIG Capital (HIG), a global private equity investment firm with USD22 billion of equity capital under management, has acquired NCI, a diversified IT and professional services company that provides software development, information assurance, IT system engineering and modernisation and other enterprise IT solutions primarily to the US

NGX Bio raises USD3m to fund growth of DNA sequencing marketplace

NGX Bio has closed a USD3 million funding round led by 180 Degree Capital Corp with participation from Third Kind Venture Capital, Lateral Capital, the Band of Angels and the Berkeley Angel Network, as well as other investors. NGX Bio was founded in 2014 to provide streamlined, on-line access to

SnapApp raises USD10.2m in Series B funding round

SnapApp, provider of an SaaS platform used by B2B marketers to create, publish, and measure interactive content, has closed USD10.2 million in additional funding from its principal investor, Providence Strategic Growth, the growth equity affiliate of Providence Equity Partners. The Series B round follows a period of sustained and rapid

VentureMed Group raises USD15m in Series B equity financing

VentureMed Group (VMG), a medical device company developing and commercialising next-generation endovascular products to treat patients suffering from peripheral artery disease (PAD), has raised USD15 million in new equity financing. The Series B Round was led by new investor Endeavour Vision, a technology and life science investor based in Geneva,

Announcement

Stroock Advises Instinet in purchase of BlockCross ATS from State Street

Law firm Stroock’s FinTech group, led by partner Ian DiBernardo and special counsel Jeffrey Mann, has advised Instinet Holdings Incorporated in its acquisition of State Street’s BlockCross ATS, an alternative trading system (ATS).  The Stroock team also included associates Binni Shah and Adam Sapper.  The transaction, which closed on August

Events

12 November, 2026 – 5:00 pm

Directory Listings